Flexomore Review 2026

Flexomore is a comprehensive joint-support formula combining glucosamine sulfate (1,500 mg), chondroitin sulfate (1,200 mg), MSM (1,000 mg), type II collagen (40 mg undenatured), and boswellia serrata (100 mg). Dosing of the three classical joint actives — glucosamine, chondroitin, and MSM — is at clinical levels that match major RCTs including the GAIT trial. UC-II collagen at 40 mg matches the Lugo et al. 2016 clinical dose. Boswellia is underdosed relative to its own evidence base (clinical trials use 300–400 mg of AKBA-standardized extract). Overall this is one of the more credible joint-health products on the retail market, recommended for adults with mild-to-moderate osteoarthritis or activity-related joint stiffness willing to commit to 8–12 weeks of daily use.

Serving is 3 capsules daily. The glucosamine + chondroitin + MSM combination matches the GAIT trial protocol exactly, which is the gold-standard RCT for combined joint support. This is a significant positive.

UC-II at 40 mg is the exact Lugo clinical dose. This is impressive attention to detail.

Boswellia at 100 mg is the one weak link — it's not enough to deliver the 5-LOX inhibition that makes boswellia clinically useful. Users specifically seeking anti-inflammatory benefit should add a standalone boswellia product or a curcumin supplement.

EU-manufactured under GMP claim. UC-II is a branded trademarked ingredient from InterHealth/Lonza, which means the manufacturer has contractual purity obligations. This is a meaningful quality signal — generic 'type II collagen' from unknown suppliers often fails potency testing.

No NSF or Informed Sport certification. No published heavy metal testing despite the product containing multiple shellfish-derived and animal-derived ingredients (glucosamine from shellfish, chondroitin from bovine or porcine cartilage). CoA available on request.

Buyers with shellfish allergies must confirm the glucosamine source — most glucosamine is crustacean-derived.

Approximately $52 for 90 capsules = 30-day supply at $1.73/day. Very competitive for a combination joint product at clinical doses. Building the stack from individual ingredients would cost approximately $1.30/day but require 4–5 separate products. Osteo Bi-Flex (the retail benchmark) runs $1.20–$1.60/day but with lower glucosamine doses in its base formulation.

Good value for the clinical-dose combination.

Most common: mild GI upset, bloating, or loose stools. Taking with food helps. Rarely: transient blood-sugar elevation in diabetics (monitor glucose if diabetic). UC-II is well-tolerated in most users. Patients on warfarin should discuss with a physician — chondroitin has mild anticoagulant effects.